178 related articles for article (PubMed ID: 32152400)
1. Cardioprotective medication adherence in Western Australians in the first year after myocardial infarction: restricted cubic spline analysis of adherence-outcome relationships.
Greenland M; Knuiman MW; Hung J; Nedkoff L; Arnet I; Rankin JM; Kilkenny MF; Sanfilippo FM
Sci Rep; 2020 Mar; 10(1):4315. PubMed ID: 32152400
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships.
Qin X; Hung J; Knuiman MW; Briffa TG; Teng TK; Sanfilippo FM
Eur J Clin Pharmacol; 2023 Apr; 79(4):553-567. PubMed ID: 36853386
[TBL] [Abstract][Full Text] [Related]
3. [Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry].
Jánosi A; Ofner P; Kiss Z; Kiss L; Kiss RG; Dinnyés J; Járai Z; Nagy G; Veress G; Ferenci T
Orv Hetil; 2017 Jul; 158(27):1051-1057. PubMed ID: 28670984
[TBL] [Abstract][Full Text] [Related]
4. Long-term medication adherence after myocardial infarction: experience of a community.
Shah ND; Dunlay SM; Ting HH; Montori VM; Thomas RJ; Wagie AE; Roger VL
Am J Med; 2009 Oct; 122(10):961.e7-13. PubMed ID: 19560749
[TBL] [Abstract][Full Text] [Related]
5. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
[TBL] [Abstract][Full Text] [Related]
6. Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.
Mathews R; Wang W; Kaltenbach LA; Thomas L; Shah RU; Ali M; Peterson ED; Wang TY
Circulation; 2018 May; 137(20):2128-2138. PubMed ID: 29386204
[TBL] [Abstract][Full Text] [Related]
7. Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.
Huber CA; Meyer MR; Steffel J; Blozik E; Reich O; Rosemann T
Clin Ther; 2019 Jan; 41(1):107-117. PubMed ID: 30591287
[TBL] [Abstract][Full Text] [Related]
8. Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors.
Zhang Y; Baik SH; Chang CC; Kaplan CM; Lave JR
Am Heart J; 2012 Sep; 164(3):425-433.e4. PubMed ID: 22980311
[TBL] [Abstract][Full Text] [Related]
9. Short- and Long-term Myocardial Infarction Survival Rate According to the Type of Drugs Prescribed at the Time of Discharge: A Study Using Iran National Registry Data.
Mozaffarian S; Taherpour N; Sistanizad M; Aghaali M; Hashemi Nazari SS
Arch Iran Med; 2022 Feb; 25(2):105-111. PubMed ID: 35429947
[TBL] [Abstract][Full Text] [Related]
10. Medication use in long-term survivors from the MONICA/KORA Myocardial Infarction Registry.
Amann U; Kirchberger I; Heier M; Thilo C; Kuch B; Meisinger C
Eur J Intern Med; 2018 Jan; 47():62-68. PubMed ID: 28826823
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
[TBL] [Abstract][Full Text] [Related]
12. Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.
Adamek KE; Ramadurai D; Gunzburger E; Plomondon ME; Ho PM; Raghavan S
J Am Heart Assoc; 2019 Feb; 8(3):e011448. PubMed ID: 30712488
[TBL] [Abstract][Full Text] [Related]
13. Comparison of medication adherence measures derived from linked administrative data and associations with mortality using restricted cubic splines in heart failure patients.
Qin X; Hung J; Knuiman MW; Briffa TG; Teng TK; Sanfilippo FM
Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):208-218. PubMed ID: 31958191
[TBL] [Abstract][Full Text] [Related]
14. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
Mathews R; Wang TY; Honeycutt E; Henry TD; Zettler M; Chang M; Fonarow GC; Peterson ED;
Am Heart J; 2015 Jul; 170(1):62-9. PubMed ID: 26093865
[TBL] [Abstract][Full Text] [Related]
15. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
JAMA Cardiol; 2020 Jan; 5(1):38-46. PubMed ID: 31721978
[TBL] [Abstract][Full Text] [Related]
16. Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia.
Livori AC; Ademi Z; Ilomäki J; Pol D; Morton JI; Bell JS
Eur J Prev Cardiol; 2024 Mar; 31(5):580-588. PubMed ID: 37987181
[TBL] [Abstract][Full Text] [Related]
17. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
Lauffenburger JC; Robinson JG; Oramasionwu C; Fang G
Circulation; 2014 Feb; 129(7):754-63. PubMed ID: 24326988
[TBL] [Abstract][Full Text] [Related]
18. Associations of kidney function with cardiovascular medication use after myocardial infarction.
Winkelmayer WC; Levin R; Setoguchi S
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1415-22. PubMed ID: 18614775
[TBL] [Abstract][Full Text] [Related]
19. Full coverage for preventive medications after myocardial infarction.
Choudhry NK; Avorn J; Glynn RJ; Antman EM; Schneeweiss S; Toscano M; Reisman L; Fernandes J; Spettell C; Lee JL; Levin R; Brennan T; Shrank WH;
N Engl J Med; 2011 Dec; 365(22):2088-97. PubMed ID: 22080794
[TBL] [Abstract][Full Text] [Related]
20. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.
Choudhry NK; Glynn RJ; Avorn J; Lee JL; Brennan TA; Reisman L; Toscano M; Levin R; Matlin OS; Antman EM; Shrank WH
Am Heart J; 2014 Jan; 167(1):51-58.e5. PubMed ID: 24332142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
